Brain disorder

Related records

Broader conditions (5)

• Central nervous system disorder
• Disease
• Disease by body system or component
• Human disease
• Nervous system disorder

Narrower conditions (1,415)

• ABeta amyloidosis, Arctic type
• ABeta amyloidosis, dutch type
• ABeta amyloidosis, Iowa type
• ABeta amyloidosis, Italian type
• ABetaA21G amyloidosis
• ABetaL34V amyloidosis
• Abetalipoproteinemia
• ABri amyloidosis
• Acquired aneurysmal subarachnoid hemorrhage
• Acquired Creutzfeldt-Jakob disease
• Acquired developmental and epileptic encephalopathy
• Acquired hyperprolactinemia
• Acquired pituitary hormone deficiency
• Acquired porencephaly
• Acquired schizencephaly
• Acquired sleep-related hypermotor epilepsy
• Acromegaly
• ACTH-dependent Cushing syndrome
• ACTH-producing pituitary gland adenoma
• ACTH-producing pituitary gland carcinoma

Trials (1,166)

• " Acute Brain Changes After Repetitive Headers in Soccer and the Effects of a Protective Device "
• 18F-DPA-714 PET/MR in Dysfunctional Brain Diseases
• 1H Magnetic Resonance Spectroscopy in Migraine Patients
• 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
• 3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)
• A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome
• A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
• A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
• A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
• A Clinical Study on Albert Wong Frame-based Stereotactic Biopsy System for Brain
• A Comparison of Dynamic Vision Between College Athletes & Controls
• A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
• A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke
• A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors
• A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement
• A First-ever Research Collaboration to Characterize MRI Measured Neural Flexibility Development in Chinese Toddlers
• A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
• A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma
• A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)
• A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

Approved drugs (2)

• Levocarnitine
• Thiamine

Drugs in development (33)

• Allopurinol Phase 3
• Apinocaltamide Phase 1
• Capecitabine Phase 3
• Charcoal, activated Phase 2
• Chloral hydrate Phase 3
• Chloroquine Phase 2
• Colistin Early phase 1
• Darbepoetin alfa Phase 2
• Dasatinib anhydrous Phase 2
• Dexmedetomidine Phase 3
• DPA-714 F-18 Phase 1
• Galantamine hydrobromide Phase 3
• Lactobacillus acidophilus Phase 3
• Lactulose Phase 3
• Lapatinib Phase 3
• Mannitol Phase 3
• Metronidazole Phase 2
• Nifuroxazide Phase 3
• Nitazoxanide Phase 3
• Ondansetron Phase 1

Other linked drugs (6)

• Gadoterate meglumine
• Gadoteridol
• Iodamide
• Iomeprol
• Pramiracetam
• Tropantiol